![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Press Releases
Pfizer and BioNTech Announce Agreement with the UK for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced an agreement with the United Kingdom to supply 30 million doses of their BNT162 mRNA-based vaccine candidate against...
News
Merck, contract research firm IRBM partner on coronavirus therapies
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that can target various strains...
News
Gilead Sciences to Acquire Tizona Therapeutics for $300 Million
Gilead Sciences, Inc. announced that it will invest $300 million to acquire a 49.9 percent equity interest in Tizona Therapeutics, Inc., a privately held...
Press Releases
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of...
Press Releases
Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
Bavarian Nordic announced the signing of an agreement with AdaptVac, a joint venture established by ExpreS2ion Biotechnologies and NextGen Vaccines spun out of the...
Clinical Trials
SGS to provide analytical testing for AstraZenecas Covid-19 vaccine
SGS will provide its services to support the development of AstraZeneca’s Covid-19 vaccine candidate – AZD1222 – which was co-invented by the University of...
News
Csafe Global appoints new Latin America director
CSafe Global, the innovation leader in active temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced that Denis Caputo has officially joined the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read